Cargando…

Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data

Detalles Bibliográficos
Autores principales: Schalling, Martin, Gleiss, Andreas, Gisslinger, Bettina, Wölfler, Albert, Buxhofer-Ausch, Veronika, Jeryczynski, Georg, Krauth, Maria-Theresa, Simonitsch-Klupp, Ingrid, Beham-Schmid, Christine, Thiele, Jürgen, Gisslinger, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802530/
https://www.ncbi.nlm.nih.gov/pubmed/29233975
http://dx.doi.org/10.1038/s41408-017-0006-y
_version_ 1783298537090449408
author Schalling, Martin
Gleiss, Andreas
Gisslinger, Bettina
Wölfler, Albert
Buxhofer-Ausch, Veronika
Jeryczynski, Georg
Krauth, Maria-Theresa
Simonitsch-Klupp, Ingrid
Beham-Schmid, Christine
Thiele, Jürgen
Gisslinger, Heinz
author_facet Schalling, Martin
Gleiss, Andreas
Gisslinger, Bettina
Wölfler, Albert
Buxhofer-Ausch, Veronika
Jeryczynski, Georg
Krauth, Maria-Theresa
Simonitsch-Klupp, Ingrid
Beham-Schmid, Christine
Thiele, Jürgen
Gisslinger, Heinz
author_sort Schalling, Martin
collection PubMed
description
format Online
Article
Text
id pubmed-5802530
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58025302018-02-08 Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data Schalling, Martin Gleiss, Andreas Gisslinger, Bettina Wölfler, Albert Buxhofer-Ausch, Veronika Jeryczynski, Georg Krauth, Maria-Theresa Simonitsch-Klupp, Ingrid Beham-Schmid, Christine Thiele, Jürgen Gisslinger, Heinz Blood Cancer J Correspondence Nature Publishing Group UK 2017-12-13 /pmc/articles/PMC5802530/ /pubmed/29233975 http://dx.doi.org/10.1038/s41408-017-0006-y Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Schalling, Martin
Gleiss, Andreas
Gisslinger, Bettina
Wölfler, Albert
Buxhofer-Ausch, Veronika
Jeryczynski, Georg
Krauth, Maria-Theresa
Simonitsch-Klupp, Ingrid
Beham-Schmid, Christine
Thiele, Jürgen
Gisslinger, Heinz
Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
title Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
title_full Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
title_fullStr Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
title_full_unstemmed Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
title_short Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
title_sort essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802530/
https://www.ncbi.nlm.nih.gov/pubmed/29233975
http://dx.doi.org/10.1038/s41408-017-0006-y
work_keys_str_mv AT schallingmartin essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata
AT gleissandreas essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata
AT gisslingerbettina essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata
AT wolfleralbert essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata
AT buxhoferauschveronika essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata
AT jeryczynskigeorg essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata
AT krauthmariatheresa essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata
AT simonitschkluppingrid essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata
AT behamschmidchristine essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata
AT thielejurgen essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata
AT gisslingerheinz essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata